CoChat

Ketamine Infusions for Chronic Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

BACKGROUND: IV ketamine is widely used to treat patients with chronic pain, yet the long-term impact remains uncertain. We synthesized evidence from randomized control trials to investigate the effectiveness of IV ketamine infusions for pain relief in chronic conditions and to determine whether any pain classifications or treatment regimens are associated with greater benefit. METHODS: We searched Medline, Embase, and Google Scholar, as well as the clinicaltrials.gov website from inception through December 16, 2017 for randomized control trials comparing IV ketamine to placebo infusions for chronic pain that reported outcomes for ≥48 hours after the intervention. Three authors independently screened the studies, pooled the data, and appraised risk of bias. Random-effects model was used to calculate weighted mean differences for pain scores and secondary outcomes. Our primary outcome was the lowest recorded pain score ≥48 hours after cessation of treatment. Secondary outcomes included responder rate and adverse effects. RESULTS: Among 696 studies assessed for eligibility, 7 met inclusion criteria. All studies except one were at high risk of bias. These studies randomly assigned 211 patients with neuropathic (n = 2), mixed (n = 2), and nonneuropathic (nociplastic or nociceptive) (n = 3) pain. Three studies reported significant analgesic benefit favoring ketamine, with the meta-analysis revealing a small effect up to 2 weeks after the infusion (mean difference in pain scores, −1.83 points on a 0–10 numerical rating scale; 95% CI, −2.35 to −1.31 points; P < .0001). In the 3 studies that reported responder rates, the proportion with a positive outcome was greater in the ketamine than in the placebo group (51.3% vs 19.4%; relative risk, 2.43; 95% CI, 1.10–5.40; P = .029; I 2 = 0.0%). No differences were noted based on pain classification or condition. Compared to low-dose ketamine studies and investigations that evaluated non–complex regional pain syndrome conditions, a small but nonsignificant greater reduction in pain scores was found among studies that either utilized high-dose ketamine therapy ( P = .213) or enrolled complex regional pain syndrome patients ( P = .079). CONCLUSIONS: Evidence suggests that IV ketamine provides significant short-term analgesic benefit in patients with refractory chronic pain, with some evidence of a dose–response relationship. Larger, multicenter studies with longer follow-ups are needed to better select patients and determine the optimal treatment protocol.

Overview

Integrity signals

Registry

Crossref · 10.1213/ane.0000000000004185

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 52 references

Research works printed but not linked: 3

  1. Cohen, 2018, Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia & Pain Medicine (ASRA), the American Academy of Pain Medicine (AAPM) and the American Society of Anesthesiologists (ASA)., Reg Anesth Pain Med, 43, 521
  2. Mailis, 2003, Sympathectomy for neuropathic pain. Mailis-Gagnon A, ed., Cochrane Database Syst Rev, 8, CD002918
  3. Chaparro, 2012, Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Pain, Palliative and Supportive Care Group, ed., Cochrane Database Syst Rev, 83, CD008943

Cited by

See all 210

Metadata

Authors
Orhurhu, V., Orhurhu, M. S., Bhatia, A., & Cohen, S. P.
Affiliations
  • Beth Israel Deaconess Medical Center (US)
  • Johns Hopkins University (US)
  • University Health Network (CA)
Corresponding author
Orhurhu, Vwaire
Venue
Anesthesia & Analgesia
Published
2019-07
Volume
129
Issue
1
Pages
241-254
ISSN
0003-2999 (ISSN-L)
OpenAlex
W2946431843
Cited by
179
References
52
Citations by year
2026: 26 · 2025: 26 · 2024: 27 · 2023: 28 · 2022: 25 · 2021: 23 · 2020: 18 · 2019: 6
FWCI
2.11
Type
journal article
Language
en
Open access
closed
Locations
  • Anesthesia & Analgesia (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
Keywords
ketamine, intravenous ketamine infusion, chronic pain, refractory pain, neuropathic pain, complex regional pain syndrome, analgesic efficacy, pain scores, responder rate, adverse effects, nociplastic pain, nociceptive pain, treatment duration, risk of bias, placebo response, long-term outcomes
MeSH terms
Adult, Analgesics, Dose-Response Relationship, Drug, Female, Humans, Infusions, Intravenous, Ketamine, Male, Middle Aged, Time Factors, Randomized Controlled Trials as Topic, Treatment Outcome, Young Adult, Chronic Pain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ketamine Infusions for Chronic Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials. https://app.cochat.ai/papers/10.1213/ane.0000000000004185
The paper
Orhurhu, V., Orhurhu, M. S., Bhatia, A., & Cohen, S. P. (2019). Ketamine Infusions for Chronic Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0000000000004185

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.